ArticleFrontiers in drug delivery2024

Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery.

R R C New et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.